1. Home
  2. VTRS vs WPC Comparison

VTRS vs WPC Comparison

Compare VTRS & WPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • WPC
  • Stock Information
  • Founded
  • VTRS 1961
  • WPC 1973
  • Country
  • VTRS United States
  • WPC United States
  • Employees
  • VTRS N/A
  • WPC N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • WPC Real Estate Investment Trusts
  • Sector
  • VTRS Health Care
  • WPC Real Estate
  • Exchange
  • VTRS Nasdaq
  • WPC Nasdaq
  • Market Cap
  • VTRS 11.0B
  • WPC 12.8B
  • IPO Year
  • VTRS N/A
  • WPC 1998
  • Fundamental
  • Price
  • VTRS $8.68
  • WPC $62.68
  • Analyst Decision
  • VTRS Hold
  • WPC Hold
  • Analyst Count
  • VTRS 4
  • WPC 12
  • Target Price
  • VTRS $10.50
  • WPC $62.82
  • AVG Volume (30 Days)
  • VTRS 17.7M
  • WPC 1.5M
  • Earning Date
  • VTRS 05-08-2025
  • WPC 04-29-2025
  • Dividend Yield
  • VTRS 5.53%
  • WPC 5.61%
  • EPS Growth
  • VTRS N/A
  • WPC N/A
  • EPS
  • VTRS N/A
  • WPC 2.09
  • Revenue
  • VTRS $14,739,300,000.00
  • WPC $1,576,386,000.00
  • Revenue This Year
  • VTRS N/A
  • WPC $4.86
  • Revenue Next Year
  • VTRS $0.99
  • WPC $5.08
  • P/E Ratio
  • VTRS N/A
  • WPC $30.00
  • Revenue Growth
  • VTRS N/A
  • WPC N/A
  • 52 Week Low
  • VTRS $8.62
  • WPC $52.91
  • 52 Week High
  • VTRS $13.55
  • WPC $66.10
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 29.72
  • WPC 56.29
  • Support Level
  • VTRS $9.01
  • WPC $60.65
  • Resistance Level
  • VTRS $9.35
  • WPC $63.48
  • Average True Range (ATR)
  • VTRS 0.27
  • WPC 1.20
  • MACD
  • VTRS 0.00
  • WPC -0.23
  • Stochastic Oscillator
  • VTRS 5.56
  • WPC 42.20

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About WPC W. P. Carey Inc. REIT

W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.

Share on Social Networks: